These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5715458)

  • 21. [Properdin level and complement activity of blood serum in children with tuberculosis receiving antibacterial therapy].
    Kostromina VP
    Probl Tuberk; 1970; 48(9):47-9. PubMed ID: 5314335
    [No Abstract]   [Full Text] [Related]  

  • 22. The content of glucosamine in serum of tuberculosis patients treated with classical drugs.
    Komorowski B; Prokopowicz D
    Acta Tuberc Pneumol Scand; 1965; 46(2):131-40. PubMed ID: 5879243
    [No Abstract]   [Full Text] [Related]  

  • 23. Diagnostic and therapeutic challenges.
    Cohen D; Rambeloarisoa J; Florea L; Leye YM; Deplus S; Gaudric A; Farge-Bancel D; Wu L; Davis J
    Retina; 2009 Jan; 29(1):117-20. PubMed ID: 18784626
    [No Abstract]   [Full Text] [Related]  

  • 24. [Ammonia and nonprotein amide nitrogen content of the blood in destructive pulmonary tuberculosis].
    Sullo KM; Poluianova RP
    Probl Tuberk; 1970; 48(7):58-61. PubMed ID: 5486085
    [No Abstract]   [Full Text] [Related]  

  • 25. [On case of "congenital tuberculosis": clinical considerations and pathogenetic findings].
    Bariffi F; Ripani P; Zeilinger G
    Arch Monaldi; 1971; 26(5):466-77. PubMed ID: 5173328
    [No Abstract]   [Full Text] [Related]  

  • 26. The histamine-binding capacity of blood serum in patients with pulmonary tuberculosis.
    Sillastu H; Hering L
    Ann Med Intern Fenn; 1967; 56(1):15-8. PubMed ID: 6040354
    [No Abstract]   [Full Text] [Related]  

  • 27. Posterior scleritis associated with systemic tuberculosis.
    Gupta A; Gupta V; Pandav SS; Gupta A
    Indian J Ophthalmol; 2003 Dec; 51(4):347-9. PubMed ID: 14750624
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Behavior of iron and of total and latent iron-binding capacity in the blood serum of patients with newly detected pulmonary tuberculosis].
    Srednicka-Zajac D
    Ann Univ Mariae Curie Sklodowska Med; 1970; 25():425-34. PubMed ID: 5525340
    [No Abstract]   [Full Text] [Related]  

  • 29. [Results of the treatment in patients with pulmonary tuberculosis excreting bacilli in primary resistance to antitubercular drugs].
    Hornung S; Polończyk M
    Gruzlica; 1965 Oct; 33(10):886-9. PubMed ID: 5881604
    [No Abstract]   [Full Text] [Related]  

  • 30. Thrombocytopenia, immune thrombocytopenia and idiopathic thrombocytopenic purpura.
    Ozsoylu S
    Turk J Pediatr; 2010; 52(2):229. PubMed ID: 20560267
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparison of the significance of C-reactive protein and erythrocyte sedimentation in the evaluation of the activity of pulmonary tuberculosis].
    Popović J; Zigić M; Petković S; Ilić M
    Tuberkuloza; 1968; 20(6):306-11. PubMed ID: 5200081
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effect of the major antitubercular drugs on selected psychical functions in adolescent with pulmonary tuberculosis. (Preliminary report)].
    Cembrzyńska K; Gurowska W; Mazur G
    Gruzlica; 1968 Aug; 36(8):723-6. PubMed ID: 5699445
    [No Abstract]   [Full Text] [Related]  

  • 33. [Morphazinamide in association with other antimycobacterial drugs in the therapy of pulmonary tuberculosis].
    Moncalvo F; Moreo GG
    Minerva Med; 1965 Sep; 56(70):2810-1. PubMed ID: 5852638
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lipoprotein metabolic study of pulmonary tuberculosis during antibacterial treatment].
    Liudvichek IA
    Probl Tuberk; 1982 Sep; (9):67-71. PubMed ID: 7145922
    [No Abstract]   [Full Text] [Related]  

  • 35. Paradoxical ascites during antituberculous chemotherapy.
    Piryani RM; Sijapati MJ; Shrestha S; Dhungana SP; Khakurel S; Acharya GP
    J Coll Physicians Surg Pak; 2013 Apr; 23(4):310. PubMed ID: 23552551
    [No Abstract]   [Full Text] [Related]  

  • 36. [Blood proteolytic systems in patients with pulmonary tuberculosis].
    Khudzik LB; Morozova TI
    Probl Tuberk; 1994; (5):56-8. PubMed ID: 7870735
    [No Abstract]   [Full Text] [Related]  

  • 37. [L-forms of Mycobacterium tuberculosis during chemotherapy of patients with chronic destructive pulmonary tuberculosis].
    Karachunskiĭ MA; Dorozhkova IR; Kaminskaia AA; Abdullaeva ET
    Probl Tuberk; 1983 Jul; (7):38-43. PubMed ID: 6415651
    [No Abstract]   [Full Text] [Related]  

  • 38. [Results of the treatment of pulmonary tuberculosis and tuberculous pleurisy with antitubercular drugs and steroids administered in cycles].
    Pregowski W; Brokman S
    Gruzlica; 1966 Feb; 34(2):135-43. PubMed ID: 5943374
    [No Abstract]   [Full Text] [Related]  

  • 39. [Reserves for enhancing the efficiency of treatment for pulmonary tuberculosis in adolescents].
    Guseĭnov GK; Pakhieva KhIu; Balashova NA
    Probl Tuberk Bolezn Legk; 2006; (1):16-9. PubMed ID: 16512179
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study on the re-treatment of pulmonary tuberculosis with special reference to resistance to primary drugs].
    Kaku R
    Kekkaku; 1968 Dec; 43(12):520-1. PubMed ID: 5716117
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.